Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hiroshi Banno
Hiroshi Banno, Osaka JP
| Patent application number | Description | Published |
|---|---|---|
| 20090258893 | FUSED QUINOLINE DERIVATIVE AND USE THEREOF - The present invention aims at provision of a quinoline derivative having a neurokinin 2 (NK2) receptor antagonistic action and relates to a compound represented by the formula (I) | 10-15-2009 |
| 20090270625 | FUSED QUINOLINE DERIVATIVE AND USE THEREOF - The present invention aims at provision of a quinoline derivative having a neurokinin 2 (NK2) receptor antagonistic action and relates to a compound represented by the formula (I) | 10-29-2009 |
| 20090275568 | FUSED QUINOLINE DERIVATIVE AND USE THEREOF - The present invention aims at provision of a quinoline derivative having a neurokinin 2 (NK2) receptor antagonistic action and relates to a compound represented by the formula (I) | 11-05-2009 |
| 20110003807 | Thiazole derivatives - The present invention relates to a compound represented by the formula (I) or (I′): | 01-06-2011 |
Hiroshi Banno, Tsukuba-Shi JP
| Patent application number | Description | Published |
|---|---|---|
| 20100004238 | FUSED HETEROCYCLIC COMPOUND - The present invention provides a fused heterocyclic compound having a tyrosine kinase inhibitory action, which is represented by the formula: | 01-07-2010 |
| 20100216788 | FUSED HETEROCYCLIC COMPOUND - The present invention provides a compound represented by the formula: | 08-26-2010 |
Hiroshi Banno, Osaka-Shi JP
| Patent application number | Description | Published |
|---|---|---|
| 20090018335 | FUSED HETEROCYCLIC COMPOUND - The present invention relates to a compound represented by the formula: | 01-15-2009 |
| 20090029973 | FUSED HETEROCYCLIC COMPOUND - The present invention relates to a compound represented by the formula: | 01-29-2009 |
| 20090203717 | FUSED HETEROCYCLIC COMPOUND - The present invention relates to a compound represented by the formula: | 08-13-2009 |
Hiroshi Banno, Aichi JP
| Patent application number | Description | Published |
|---|---|---|
| 20090047319 | Pharmaceutical composition for obstructive vascular disease - Provided is the excellent prevention or treatment of a vascular occlusive disease such as vascular restenosis. A pharmaceutical composition for a obstructive vascular disease comprising a nucleic acid construct capable of inhibiting the expression of a midkine gene through RNA interference and a collagen molecule. The use of the nucleic acid construct capable of inhibiting the expression of an MK protein through RNA interference in the presence of the collagen molecule can provide an excellent inhibitory effect on the thickened vascular intima. | 02-19-2009 |